Log In
Print this Print this

brivaracetam (Briviact) (formerly Rikelta)

Also known as: UCB 34714

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionHigh affinity synaptic vesicle protein (SV2A) ligand
Molecular Target Synaptic vesicle protein (SV2A)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today